Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter to the Editor
  • Published:

Angiotensin II Receptor Antagonist in Pregnancy

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Saji H, Yamanaka M, Hagiwara A, Ijiri R . Losartan and fetal toxic effects. Lancet 2001;357:363.

    Article  CAS  Google Scholar 

  2. Briggs GG, Nbageotte MP . Fatal outcome with the combined use of valsartan and atenolol. Ann Pharmacoth 2001;35:859–61.

    Article  CAS  Google Scholar 

  3. Martinovic J, Benachi A, Laurent N, Da-Dahmane F, Gubler MC . Fetal toxic effects and angiotensin-II receptor antagonists. Lancet 2001;358:241–2.

    Article  CAS  Google Scholar 

  4. Hinsberger A, Wingen AM, Hoyer PF . Letter. Lancet 2001;357:1620

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Morville, P. Angiotensin II Receptor Antagonist in Pregnancy. J Perinatol 24, 56–57 (2004). https://doi.org/10.1038/sj.jp.7211011

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jp.7211011

This article is cited by

Search

Quick links